Crispr Therapeutics shares owned by Hedges Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hedges Asset Management
from 13F filings
Historical chart of Hedges Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Hedges Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Hedges Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 23k | 47.00 |
| 2024-06-30 | $1.2M | 22k | 54.01 |
| 2024-03-31 | $1.3M | 19k | 68.16 |
| 2023-12-31 | $1.3M | 21k | 62.60 |
| 2023-09-30 | $1.0M | 23k | 45.39 |
| 2023-06-30 | $1.1M | 19k | 56.14 |
| 2023-03-31 | $737k | 16k | 45.23 |
| 2022-12-31 | $637k | 16k | 40.65 |
| 2022-09-30 | $685k | 11k | 65.39 |
| 2022-06-30 | $753k | 12k | 60.85 |
| 2022-03-31 | $614k | 9.8k | 62.81 |
| 2021-12-31 | $633k | 8.4k | 75.81 |